Yahoo Finance

Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

Cannabis Science Announces Update on Proposed DPI Inhalation Device, CBD Infused Pain Patch, and Extends Praise for President Trump's Support of Medical Cannabis, Nationwide

IRVINE, CA--(Marketwired - Feb 24, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce updates on the ...
PharmTech

Dry powder inhalers: challenges and goals for next generation therapies

There have been significant advances, especially in understanding the role of carrier properties on the aerosol performance of the API. Dry powder inhalers (DPIs) have advanced significantly over the ...
PharmTech

Hovione Technology Develops Blister-Based Inhaler

A simple, one-part DPI aims to make inhalation drug treatment more accessible and affordable. Hovione Technology, a Hovione Ventures company, announced in an April 15, 2019 press release that it has ...
Nasdaq

Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA

WESTLAKE VILLAGE, Calif. and DANBURY, Conn., April 19, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the development ...